CD4+TSIV

Norman L Letvin1, John R Mascola, Yue Sun

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. nletvin@bidmc.harvard.edu

Science (New York, N.Y.)
|June 10, 2006
PubMed
概括

疫苗诱导的细胞免疫在子中暂时控制了猿类免疫缺陷病毒 (SIV) 复制,但与保存的CD4+T细胞相关的长期存活,表明艾滋病疫苗的潜力.